Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Anandagoda N; School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.; Willis JC
Subjects: Immune Tolerance*; Cyclic Nucleotide Phosphodiesterases, Type 3/Cyclic Nucleotide Phosphodiesterases, Type 3/Cyclic Nucleotide Phosphodiesterases, Type 3/*immunology ; Gene Expression Regulation, Enzymologic/Gene Expression Regulation, Enzymologic/Gene Expression Regulation, Enzymologic/*immunology
-
Source:
The Journal of clinical investigation [J Clin Invest] 2019 Mar 01; Vol. 129 (3), pp. 1257-1271. Date of Electronic Publication: 2019 Feb 11.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:
Record details
-
Authors :
Masciarelli S; Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland 20892, USA.; Horner K
Subjects: Infertility, Female*/Infertility, Female*/Infertility, Female*/genetics; 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*metabolism; 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/genetics
-
Source:
The Journal of clinical investigation [J Clin Invest] 2004 Jul; Vol. 114 (2), pp. 196-205.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:
Record details
-
Authors :
Wiersma A; Department of Pharmacology, N.V. Organon, P.O. Box 20, 5340 BH Oss, The Netherlands. ; Hirsch B
Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Contraceptive Agents, Female/Contraceptive Agents, Female/Contraceptive Agents, Female/*pharmacology ; Cyclic AMP/Cyclic AMP/Cyclic AMP/*physiology
-
Source:
The Journal of clinical investigation [J Clin Invest] 1998 Aug 01; Vol. 102 (3), pp. 532-7.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:
Record details